Comment Business & Economics
Lonza to build formulation plant for Meta metaldehyde
By Gerald Ondrey |
Lonza (Basel, Switzerland; www.lonza.com) is investing CHF 5.8 million ($8 million) in a formulation plant for Meta metaldehyde. This will enable Lonza to supply its own formulations, allowing the company in the future to serve the market not only with metaldehyde as an active substance, but also with ready-made slug pellets.
The establishment of this formulation plant, which is expected to become operational in the second half of 2012, is part of the Nutrition business unit’s consistent implementation of its strategic focus. The formulation of slug pellets will enable the company to add a further planned link in the value chain toward end-customers.
Construction of the formulation plant in Visp, Switzerland, will strengthen the site in its strategy to supply technologically demanding products with a high degree of in-house contribution in the areas of technology, processes and patentability.
Related Content The U.S. Chemical Production Regional Index (U.S. CPRI) rose 0.8% in January following a 1.4% gain in December and a…
The American Chemistry Council (ACC; Washington, D.C.; www.americanchemistry.com) reported that U.S. specialty chemicals market volumes rose 1.2% in January, accelerating…
The following is a list of recently published books that may be relevant for professionals in the chemical process industries…
Plant Watch Austria’s largest green-hydrogen plant being constructed at OMV refinery February 16, 2021 — OMV AG (Vienna, Austria; www.omv.com)…
The Chemical Activity Barometer (CAB), a leading economic indicator created by the American Chemistry Council (ACC; Washington, D.C.; www.americanchemistry.com), rose…
Breakthrough Technologies
Chemical Engineering publishes FREE eletters that bring our original content to our readers
in an easily accessible email format about once a week.
Subscribe Now
Subscribe Now
Job Listings
